![Dominic Borie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dominic Borie
Directeur Technique/Scientifique/R&D chez
CUE BIOPHARMA, INC.
Fortune : 803 880 $ au 31/08/2026
Profil
Dr. Dominic Borie is a Chief Medical Officer, Head-Research & Development at Cue Biopharma, Inc. Dr. Borie was previously employed as a President-Research & Development by Kyverna Therapeutics, Inc., a VP, Head-External Research & Development by Horizon Therapeutics Ltd. (Ireland), a Senior Medical Director by Genentech, Inc., a Medical Director by Amgen, Inc., a Director-Transplantation Research by Roche Pharmaceuticals, Inc., a Director-Transplantation Immunology Laboratory by Stanford University, and an Executive Director by Allogene Therapeutics, Inc. He received his undergraduate degree from North Carolina State University, a doctorate degree from Universite Paris Est Creteil Val De Marne, a doctorate degree from Universite Paris Cite and a doctorate degree from The University of Texas at Austin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,43 % | 13/07/2026 | 31 500 ( 0,43 % ) | 803 880 $ | 31/08/2026 |
Postes actifs de Dominic Borie
| Sociétés | Poste | Début |
|---|---|---|
| CUE BIOPHARMA, INC. | Directeur Technique/Scientifique/R&D | 13/07/2026 |
Anciens postes connus de Dominic Borie
| Sociétés | Poste | Fin |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Directeur Général | 13/10/2022 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01/01/2020 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur Technique/Scientifique/R&D | 01/02/2016 |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/08/2013 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01/12/2007 |
Formation de Dominic Borie
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
 North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universite Paris Est Creteil Val De Marne
 Universite Paris Est Creteil Val De Marne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Universite Paris Cite
 Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
